FREMONT, Calif.--(BUSINESS WIRE)-- Cordis Corporation today announced it has received clearance from the Food and Drug Administration of its latest innovation in guiding catheters: the ADROIT TM 6F ...

The FDA determined this week that Cordis’ recent recall of several versions of its Super Torque angiographic catheters meet the criteria of a Class I recall, a label reserved for those the agency ...

Cordis, a unit of Johnson & Johnson, announced the launch of its SABER PTA Dilatation Catheter for the treatment of patients with Peripheral Arterial Disease. The SABER Catheter is cleared for use and ...

FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today that it has entered into an agreement with TriReme Medical, Inc. that grants the company exclusive distribution rights for the ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014” Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter designed to ...

Cordis is recalling the Super Torque MB angiographic catheter with radiopaque marker bands, the US Food and Drug Administration announced this week, categorizing the action as a class I recall, the ...

Today at the 61st Annual Meeting of the Society for Vascular Surgery, Cordis Endovascular, division of Cordis Corporation, announced the worldwide launch of the Cordis AVIATOR(TM) Plus Balloon ...

Medical devices group Clearstream Technologies has signed a landmark deal with US health care giant Johnson & Johnson. The Arklow-based manufacturer of cardiac intervention devices has agreed to ...